Elite Pharmaceuticals (OTCMKTS:ELTP) Stock Price Passes Below Two Hundred Day Moving Average – Here’s Why

Elite Pharmaceuticals Inc. (OTCMKTS:ELTP) shares passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.39 and traded as low as $0.3678. Elite Pharmaceuticals shares last traded at $0.3875, with a volume of 616,828 shares trading hands.

Elite Pharmaceuticals Trading Up 3.3%

The firm has a market capitalization of $417.39 million, a P/E ratio of 19.38 and a beta of 0.39. The business’s 50 day moving average is $0.37 and its two-hundred day moving average is $0.39. The company has a quick ratio of 5.22, a current ratio of 6.45 and a debt-to-equity ratio of 0.04.

About Elite Pharmaceuticals

Elite Pharmaceuticals, Inc is a U.S.-based specialty pharmaceutical company that acquires, develops and markets both branded and generic pharmaceutical products. Headquartered in Houston, Texas, the company focuses on complex dosage forms—including injectables, sterile formulations and oncology therapies—and seeks to address unmet medical needs through advanced drug delivery technologies. Its product portfolio spans therapeutic areas such as pain management, oncology and cardiovascular care.

Since its founding in 2007, Elite Pharmaceuticals has pursued strategic partnerships and licensing agreements to expand its pipeline and manufacturing capabilities.